{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:23:07Z","timestamp":1790893387522,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2020\/001735"],"award-info":[{"award-number":["CRG\/2020\/001735"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Mycology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.mycmed.2022.101306","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T11:53:14Z","timestamp":1655812394000},"page":"101306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Multidrug resistant tinea corporis\/cruris: Response to voriconazole"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7020-7777","authenticated-orcid":false,"given":"Ananta","family":"Khurana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aastha","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diksha","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kabir","family":"Sardana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Chowdhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2022.101306_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.fgb.2019.103255","article-title":"Antifungal resistance in dermatophytes\u2013Recent trends and therapeutic implications","volume":"132","author":"Khurana","year":"2019","journal-title":"Fungal Genet Biol"},{"key":"10.1016\/j.mycmed.2022.101306_bib0002","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/17512433.2019.1604218","article-title":"Parameters that determine dissolution and efficacy of itraconazole and its relevance to recalcitrant dermatophytoses","volume":"12","author":"Sardana","year":"2019","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.mycmed.2022.101306_bib0003","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s11046-020-00455-8","article-title":"Trichophyton indotineae sp. nov.\u2013A new highly terbinafine-resistant anthropophilic dermatophyte species","volume":"185","author":"Kano","year":"2020","journal-title":"Mycopathologia"},{"key":"10.1016\/j.mycmed.2022.101306_bib0004","unstructured":"Clinical Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi Third Edition. CLSI document M38-Ed3. 2017."},{"key":"10.1016\/j.mycmed.2022.101306_bib0005","unstructured":"Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A2, 2nd ed. Clinical and Laboratory Standards Institute, Wayne, PA. 2010."},{"key":"10.1016\/j.mycmed.2022.101306_bib0006","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/myc.13367","article-title":"Predicting a therapeutic cut-off serum level of itraconazole in recalcitrant tinea corporis and cruris-A prospective trial","volume":"64","author":"Khurana","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2022.101306_bib0007","doi-asserted-by":"crossref","first-page":"e14891","DOI":"10.1111\/dth.14891","article-title":"Re-emerging role of KOH smear examination in the era of recalcirant dermatophytoses","volume":"34","author":"Khurana","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.mycmed.2022.101306_bib0008","doi-asserted-by":"crossref","first-page":"e01018","DOI":"10.1128\/AAC.01038-18","article-title":"Correlation of in vitro susceptibility based on MICs and squalene epoxidase mutations with clinical response to terbinafine in patients with tinea corporis\/cruris","volume":"62","author":"Khurana","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2022.101306_bib0009","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2147\/IDR.S246025","article-title":"Emergence of terbinafine resistant Trichophyton mentagrophytes in Iran, harboring mutations in the squalene epoxidase (SQLE) gene","volume":"13","author":"Taghipour","year":"2020","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.mycmed.2022.101306_bib0010","doi-asserted-by":"crossref","first-page":"e01116","DOI":"10.1128\/AAC.01126-19","article-title":"Emerging terbinafine resistance in Trichophyton\u2013Clinical characteristics, squalene epoxidase gene mutations, and a reliable EUCAST method for detection","volume":"63","author":"Saunte","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2022.101306_bib0011","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/jof8030220","article-title":"Terbinafine resistance in dermatophytes\u2013A French multicenter prospective study","volume":"8","author":"Moreno-Sabater","year":"2022","journal-title":"J Fungi"},{"key":"10.1016\/j.mycmed.2022.101306_bib0012","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1473-3099(18)30079-3","article-title":"Emergence of recalcitrant dermatophytosis in India","volume":"18","author":"Bishnoi","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.mycmed.2022.101306_bib0013","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/jdv.17241","article-title":"Emerging antifungal treatment failure of dermatophytosis in Europe\u2013Take care or it may become endemic","volume":"35","author":"Saunte","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.mycmed.2022.101306_bib0014","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4103\/idoj.IDOJ_253_19","article-title":"Clinical implications of antifungal drug susceptibility testing of dermatophytes","volume":"10","author":"Khurana","year":"2019","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.mycmed.2022.101306_bib0015","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11046-013-9655-y","article-title":"Increase in resistance to fluconazole and itraconazole in Trichophyton rubrum clinical isolates by sequential passages in vitro under drug pressure","volume":"176","author":"Hryncewicz-Gw\u00f3\u017ad\u017a","year":"2003","journal-title":"Mycopathologia"},{"key":"10.1016\/j.mycmed.2022.101306_bib0016","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1128\/AAC.02382-13","article-title":"Potential of Ergosterol synthesis inhibitors to cause resistance or cross-resistance in Trichophyton rubrum","volume":"58","author":"Ghelardi","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2022.101306_bib0017","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/bjd.19420","article-title":"Treatment-resistant tinea corporis, a potential public health issue","volume":"184","author":"Chen","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.mycmed.2022.101306_bib0018","doi-asserted-by":"crossref","first-page":"e14014","DOI":"10.1111\/dth.14014","article-title":"Successful treatment of resistant onychomycosis with voriconazole in a liver transplant patient","volume":"33","author":"Nofal","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.mycmed.2022.101306_bib0019","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/jac\/dkw045","article-title":"Trough concentration of voriconazole and its relationship with efficacy and safety\u2013A systematic review and meta-analysis","volume":"71","author":"Jin","year":"2016","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523322000634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523322000634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:19:19Z","timestamp":1778591959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523322000634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1156523322000634"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2022.101306","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multidrug resistant tinea corporis\/cruris: Response to voriconazole","name":"articletitle","label":"Article Title"},{"value":"Journal of Medical Mycology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2022.101306","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 SFMM. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101306"}}